Tff Pharmaceuticals Inc

NASDAQ:TFFP   4:00:00 PM EDT
1.16
+0.01 (+0.87%)
Earnings Announcements

TFF Pharmaceuticals Reports Third Quarter 2022 Financial Results, Provides Business Update

Published: 11/14/2022 21:23 GMT
Tff Pharmaceuticals Inc (TFFP) - Tff Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update.
As of September 30, 2022, Tff Pharmaceuticals Reported Cash and Cash Equivalents of $13.1 Million.
Qtrly Net Loss per Share, Basic and Diluted $0.29.
Q3 Earnings per Share View $-0.33 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.32

More details on our Analysts Page.